首页 > 市场调查报告书 > 医疗设备

心血管设备

市场调查报告书

商品编码

1374811

全球体外心臟去颤器市场 -2023-2030

Global External Defibrillators Market -2023-2030

出版日期: 2023年11月01日 | 出版商:

DataM Intelligence | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

概述

体外去颤器主要用于治疗心室颤动（快速且不规则的心跳）和室性心动过速（致命的快速心跳）。作为一种紧急救生设备，它包括电池和电极片，可以检测和分析患者的心律并提供电击。

如果发生心臟骤停，成人可以使用自动体外心臟去颤器 (AED) 进行体外去颤。该设备提供有关如何检查患者脉搏、呼吸和放置电极片的说明。 AED分析患者的心律，确定是否需要电击，并在电击后指导心肺復苏术。这个过程一直持续到救援人员到达并提供高级生命维持 (ALS) 治疗为止。

AED 是一种电脑化去颤器，可以自动分析心臟骤停患者的心律。在适当的时候，它会对心臟进行电击，以恢復其正常节律。 AED 系统包括电池和电极片等配件，这些配件是 AED 检测和解释人的心律并在需要时提供电击所必需的。

市场动态：驱动因素与限制因素

心律不整盛行率上升

心律不整很常见，但某些类型比其他类型更常见。最常见的是心房性早期心搏（PAC）和心房颤动。心房颤动影响大约五分之一的 65 岁以下美国人和大约十分之一的 65 岁以上美国人。室性心律不整的发生率差异很大。在一项研究中，每 10 万名成年人中有 48 人（约 2,100 人中就有 1 人）发生室性心律不整。在老年人中，每100 名没有任何已知危险因子的人中，就有2-3 人发生室性心律不整，每100 名患有冠状动脉疾病(CAD) 的人中，有15-16 人发生室性心律不整。

预计政府、监管机构和医疗机构将推出越来越多的支持政策，这将在预测期内推动市场发展。例如，IRC（义大利復苏委员会）报告称，义大利关于 AED 的拟议法律已于 2021 年 7 月获得该商会社会事务委员会的批准。

此外，全球体外心臟去颤器市场受到技术进步、新颖产品发布以及与主要参与者的合作等多种因素的推动，将进一步推动预测期内的市场成长。

市场动态：克制

产品召回是预测期内阻碍市场成长率的主要因素之一。例如，2023 年7 月，美敦力召回了带有玻璃馈通的植入式心律转復除颤器(ICD) 和心臟再同步治疗除颤器(crt-ds)，以应对高压治疗期间能量输出低或无能量输出的风险。

此外，严格的法规以及缺乏对心臟骤停（SAC）的认识和早期纠正措施等因素可能会阻碍预测期内市场的成长。此外，网路安全是除颤器市场的另一个主要问题。新一代植入式除颤器技术先进，可实现远端资料传输。

An external defibrillator is mainly used to treat ventricular fibrillation (fast and irregular heartbeat) and ventricular tachycardia (fatal rapid heartbeat). As an emergency life-saving device, it includes batteries and electrode pads that detect and analyze the patient's heart rhythm and deliver electrical shocks.

Adults can perform external defibrillation using an Automated External Defibrillator (AED) in case of a cardiac arrest. The device provides instructions on how to check the patient's pulse, breathe, and place electrode pads. The AED analyses the patient's heart rhythm, determines if a shock is needed, and guides through cardiopulmonary resuscitation after the shock. The process continues until help arrives to provide advanced life support (ALS) treatment.

AEDs are a type of computerized defibrillator that automatically analyzes the heart rhythm in people who are experiencing cardiac arrest. When appropriate, it delivers an electrical shock to the heart to restore its normal rhythm. The AED system includes accessories, such as a battery and pad electrodes, that are necessary for the AED to detect and interpret a person's heart rhythm and deliver an electrical shock if needed.

Market Dynamics: Drivers and Restraints

Rise in the Prevalence of cardiac arrhythmias

Arrhythmias are common, but some types are more common than others. The most common are premature atrial complexes (PACs) and atrial fibrillation. Atrial fibrillation affects about 1 in 50 Americans under the age of 65 and about 1 in 10 Americans over age 65. The incidence of ventricular arrhythmias varies widely. In one study, ventricular arrhythmias occurred in 48 per 100,000 adults (approximately 1 in 2,100 people). In older adults, ventricular arrhythmias occur in 2-3 out of 100 people who do not have any known risk factors, and in 15-16 in 100 people who have coronary artery disease (CAD).

An increasing number of supportive policies by governments, regulatory bodies, and healthcare organizations is anticipated to fuel the market over the forecast period. For example, the IRC (Italian Resuscitation Council) reported that the proposed law on AEDs in Italy was approved by the social affairs commission of the chamber in July 2021.

Furthermore, the global external defibrillators market is driven by various factors like technological advancements, novel product launches, and collaboration with key players will further drive the market growth during the forecast period.

Market Dynamics: Restraint

Product recalls is one of the major factor that hampers the market growth rate during the forecast period. For instance, in July 2023, Medtronic recalled implantable cardioverter defibrillators (ICD) and cardiac resynchronization therapy defibrillators (crt-ds) with glassed feedthrough for risk of low or no energy output during high voltage therapy.

Also, factors such as stringent regulations and lack of awareness and early corrective measures about Sudden Cardiac Arrest (SAC) may hinder the growth of the market over the forecast period. Moreover, Cybersecurity is another major concern in the defibrillators market. The new generation of implantable defibrillators is technologically advanced, allowing for remote data transfer.

Segment Analysis

The global external defibrillators is segmented based on product type, technology, end-user and region.

The automated external defibrillators segment from the product type accounted for approximately 41.2% of the market share

The automated external defibrillators segment from the product type accounted for 41.2% and it is expected to be dominated during the forecast period. An automated external defibrillator AED is a portable medical device that delivers a shock to the heart through the chest wall in order to restore normal heart rhythm. AEDs are used to treat victims of sudden cardiac arrest (SCA), which is when the heart stops beating unexpectedly. When someone who is suffering from life-threatening arrhythmias goes into sudden cardiac arrest, time is critical.

Automated external defibrillators (AED) are mostly found in public access settings and are meant to be used by non-medical personnel. If someone suffers sudden cardiac arrest, people nearby can provide CPR and use an AED before the ambulance arrives. When turned on, the AED will give the user step-by-step directions to deliver a shock if needed. The person using the AED needs to follow the instructions and the AED will start functioning automatically. This increases the demand for the AED and accelerates the segment's growth.

For instance, in March 2023, Safe Life acquired Coro Medical and AED.us, a national market player in automated external defibrillator (AED) sales and services, to expand life-saving equipment and services across the United States.

Furthermore, in January 2023, Avive Solutions received FDA approval for its Handheld automated external defibrillator with unique capabilities. Avive Connect AED combines cellular and WiFi connectivity, GPS technology, remote maintenance, and extreme portability in the handheld device.

Geographical Analysis

North America accounted for approximately 38.4% of the market share in 2022

North America is estimated to hold about 38.4% of the total market share throughout the forecast period owing to the supportive regulations to increase the availability of public access AEDs, and the high adoption of external defibrillators at healthcare facilities. Many national organizations in the U.S., including the American Heart Association (AHA), recommend the implementation of comprehensive Public Access Defibrillation (PAD) programs.

For instance, in June 2020, Royal Philips, a global leader in health technology, stated that the Center for Devices and Radiological Health (CDRH) of the U.S. Food and Drug Administration has granted premarket approval (PMA) for the company's HeartStart FR3 and HeartStart FRx automated external defibrillators (AEDs), and their supporting accessories, including batteries and pads.

COVID-19 Impact Analysis

COVID-19 had a substantial impact on the global external defibrillators market arrhythmias were observed in many COVID patients, but in-hospital defibrillator facilities helped save their lives. Due to the virus outbreak, many surgical procedures were cancelled or postponed, depending on the criticality of the patient. This resulted in losses for companies.

COVID-19 also impacted various stages of the value chain, primarily due to strict lockdowns imposed by the governments of most countries. The turnaround time for the delivery of products and services was also affected due to countries' newer packaging protocols and lockdown measures. All these factors negatively impacted the manufacturing and supply chain of the defibrillators market.

Competitive Landscape

The major global players in the external defibrillators market include: Koninklijke Philips N.V, Advin Health Care, ZOLL Medical Corporation, Defibtech, LLC., Stryker, ClJ Medical System Inc., Avive Solutions, Inc, Schiller AG, MEDIANA Co., Ltd, ViVest Medical Technology Co and among others.

Key Developments

In January 2023, Avive Solutions, Inc., received U.S. Food and Drug Administration (FDA) pre-market approval (PMA)-- the agency's highest level of approval- for its Avive AED, a unique automated external defibrillator.
In April 2022, Kestra Medical Technologies stated that the company's ASSURE Wearable Cardioverter Defibrillator (WCD) system is effective at reducing false-positive shock alarms according to results of the ASSURE clinical evaluation detection and safety study published in the journal of cardiovascular electrophysiology.

Why Purchase the Report?

To visualize the global external defibrillators market segmentation-based product type, technology, end-user and region, as well as understand key commercial assets and players.
Identify commercial opportunities by analysing trends and co-development
Excel data sheet with numerous data points of external defibrillators market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as excel consisting of key products of all the major players.

The global external defibrillators market report would provide approximately 69 tables, 70 figures, and 185 Pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product Type
3.2. Snippet by Technology
3.3. Snippet by End User
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Driver
  - 4.1.1.1. Rise in the prevalence of cardiac arrhythmias
  - 4.1.1.2. Increasing number of supportive policies by governments
- 4.1.2. Restraints
  - 4.1.2.1. Product recalls
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Russia-Ukraine War Impact Analysis
5.6. DMI Opinion

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID
- 6.1.2. Scenario During COVID
- 6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. By Product Type

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 7.1.2. Market Attractiveness Index, By Product Type
7.2. Automated External Defibrillators *
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Manual External Defibrillators
7.4. Wearable Cardioverter Defibrillators

8. By Technology

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 8.1.2. Market Attractiveness Index, By Technology
8.2. Monophasic Defibrillation *
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Biphasic Defibrillation

9. By End User

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.1.2. Market Attractiveness Index, By End User
9.2. Hospitals *
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Clinics
9.4. Home Care Services
9.5. Ambulatory Surgical Centers

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.6.1. U.S.
  - 10.2.6.2. Canada
  - 10.2.6.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.6.1. Germany
  - 10.3.6.2. UK
  - 10.3.6.3. France
  - 10.3.6.4. Italy
  - 10.3.6.5. Spain
  - 10.3.6.6. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.6.1. Brazil
  - 10.4.6.2. Argentina
  - 10.4.6.3. Rest of South America
10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.6.1. China
  - 10.5.6.2. India
  - 10.5.6.3. Japan
  - 10.5.6.4. Australia
  - 10.5.6.5. Rest of Asia-Pacific
10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

12.1. Koninklijke Philips N.V
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio and Description
- 12.1.3. Financial Overview
- 12.1.4. Key Developments
12.2. Advin Health Care
12.3. ZOLL Medical Corporation
12.4. Defibtech, LLC.
12.5. Stryker
12.6. ClJ Medical System Inc.
12.7. Avive Solutions, Inc
12.8. Schiller AG
12.9. MEDIANA Co., Ltd
12.10. ViVest Medical Technology Co

LIST NOT EXHAUSTIVE